Cyclobenzaprine, Urine

Purpose

Therapeutic Drug Monitoring

Method(s)

High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)

Suggested CPT Code(s)

80369

New York State Approval Status

Approved

Turnaround Time

4 days

Test Includes


1	Cyclobenzaprine	Flexeril®	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Muscle Relaxant

Specimen Type

Urine

Requested Volume

1 mL

Minimum Volume

0.4 mL

Special Handling

None

Specimen Container

Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature

Refrigerated

Light Protection

Not Required

Rejection Criteria

None

Rejection criteria pertain to clinical specimen submissions only.

Stability

Room Temperature: 30 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): 30 day(s)


1	Cyclobenzaprine	Flexeril®	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Muscle Relaxant

Example Report (Negative)

Example Report (Positive)

Interface Map

1405U Cyclobenzaprine, Urine - Current Version
Analyte	Units	Analyte Mapping Code	LOINC®
Cyclobenzaprine	ng/mL	CYCLOBENZA	14061-6

LOINC^® Information

1405U Cyclobenzaprine, Urine - Current Version
Analyte	Units	Analyte Mapping Code	LOINC®
Cyclobenzaprine	ng/mL	CYCLOBENZA	14061-6


Some LOINC^® codes may not have been assigned or are not available. The LOINC^® codes are copyright © 1995-2017, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. All rights reserved. Additional information can be found at LOINC.org.

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.